Improving API Synthesis - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Improving API Synthesis
O-arylation and O-alkylation, a one-pot protein synthesis, a combined approach in continued and chemocatalysis, and green-chemistry applications are the target of some recent advances in API synthesis.


Pharmaceutical Technology
Volume 35, Issue 8, pp. 52-56

Suzuki-Miyaura cross couplings in a continuous flow system

Researchers at the Massachusetts Institute of Technology (MIT) reported on the development of a Suzuki–Miyaura cross-coupling reaction in a continuous-flow microreactor system. Specifically, the researchers reported on a continuous-flow Suzuki–Miyaura cross-coupling reaction that started from phenols and produced various biaryls in good yield using a microfluidic-extraction operation and a packed-bed reactor. The project used a multidisciplinary approach with the research on microreactor technology developed by a team led by Klaus F. Jensen, department head, Warren K. Lewis professor of chemical engineering, and professor of materials science and engineering at MIT. The organic synthesis portion of the project was developed by a group led by Stephen Buchwald, Camille Dreyfus professor of chemistry at MIT (4, 5).

Suzuki coupling is a palladium-catalyzed coupling between organoboron compounds and organohalides and is an important reaction in organic chemistry in general and in the development of pharmaceutical compounds specifically. Akira Suzuki, distinguished professor emeritus at Hokkaido University in Sapporo, Japan, was a corecipient of the 2010 Nobel Prize in Chemistry for the development of palladium-catalyzed cross coupling (6).

Although batch manufacturing is the predominant form of manufacturing in the pharmaceutical industry, there is growing interest in microreactor technology. In general, microstructured devices with small internal volumes and high surface-to-volume ratios offer transport capabilities for rapid mixing, enhanced heat transfer for good temperature control, and intensified mass transfer. Microstructured devices operate in continuous-flow environment, which can offer certain advantages, such as controlled process conditions, high flow rates, and high mass throughput. Continuous operations also may allow bulk-chemistry processes to have high production capacities. Fluid dynamics determine the characteristics of continuous-flow equipment such as pressure loss, residence time, heat-transfer characteristics, and mixing time (7).

Buchwald is engaged in various research projects involving catalysis, including the creation and study of new ligands, the design of new methods to form carbon–nitrogen bonds through the use of metal catalysts, such as palladium or copper, new methods for the formation of carbon–carbon bonds, including asymmetric transformations, as well as continuous flow chemistry using microreactors and capillary tubing. Buchwald recently reported on the continuous-flow synthesis of 3,3-disubstituted oxindoles by a palladium-catalyzed a-arylation/alkylation sequence. Specifically, he reported on the pallidum-catalyzed a-arylation of oxindoles in continuous flow involving a biphasic system, a precatalyst, and a packed-bed microreactor. The reaction was integrated into a two-step continuous-flow sequence for rapid, modular, and efficient syntheses of 3,3-disubstituted oxindoles (8).

Jensen's research is focused on understanding and controlling the interaction of reaction and transport processes in realizing and testing functional microstructured and nanostructured materials and devices for chemical, biological, optical, electronic, and energy applications, including the use of microfabricated systems. He recently reported on research using an automated microfluidic system for online optimization in chemical synthesis. He reported that the time and material required for an optimization trial were minimized by performing reactions in an integrated silicon microreactor and incorporating high-performance liquid chromatography for in-line monitoring of the reaction performance. The system was used to optimize two different reactions to understand the potential impact of the system for reaction development. The two reactions studied were a Knoevenagel condensation reaction and a mulitparameter optimization to maximize the yield of benzaldehyde in the oxidation pathway of benzyl alcohol to benzaldehyde to benzoic acid (9).

In other work, Jensen's team reported on the design and use of a high-pressure and high-temperature microsystem. Key parameters for the fabrication of the microreactors and modular fluidic packaging were to withstand high pressure and temperature conditions (i.e., 30MPa and 400 C). The researchers reported on various applications of the high-pressure/high-temperature plug and play microsystems. These applications included multiphase follow visualization through the transition of liquid–liquid immiscible hexane–water segmented flow to homogeneous supercritical flow, on-chip supercritical water oxidation, and synthesis of iron oxide nanoparticles (10).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here